DOI: 10.1007/s00259-017-3657-9Pages: 1099-1100

213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer

1. University of Pretoria, Department of Nuclear Medicine, Steve Biko Academic Hospital

2. NTP Radioisotopes, The South African Nuclear Energy Corporation, Pelindaba

3. ITG Isotope Technologies Garching GmbH

Correspondence to:
Mike Sathekge
Email: mike.sathekge@up.ac.za

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Accepted: Feb 14, 2017
  • Online: Mar 2, 2017

Article Tools

eanm
EJNMMI Ad